These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5580287)

  • 41. Pimecrolimus cream in repigmentation of vitiligo.
    Seirafi H; Farnaghi F; Firooz A; Vasheghani-Farahani A; Alirezaie NS; Dowlati Y
    Dermatology; 2007; 214(3):253-9. PubMed ID: 17377388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of vitiligo with 8-methoxypsoralen.
    van Dijk E
    Dermatologica; 1967; 134(5):345. PubMed ID: 6048407
    [No Abstract]   [Full Text] [Related]  

  • 43. [Internal treatment of vitiligo].
    Hofmann C
    Hautarzt; 1978 May; 29(5):298-9. PubMed ID: 659113
    [No Abstract]   [Full Text] [Related]  

  • 44. Topically administered fluorouracil in vitiligo.
    Tsuji T; Hamada T
    Arch Dermatol; 1983 Sep; 119(9):722-7. PubMed ID: 6614958
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral phenylalanine loading and sunlight as source of UVA irradiation in vitiligo on the Caribbean island of Curacao NA.
    Kuiters GR; Hup JM; Siddiqui AH; Cormane RH
    J Trop Med Hyg; 1986 Jun; 89(3):149-55. PubMed ID: 3773027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study of repigmentation patterns and dermatoscopic features in vitiligo treated with various modalities.
    Sharma A; Arpitha R; Kumaran MS; Prakash A; Parsad D
    Arch Dermatol Res; 2024 Jun; 316(7):432. PubMed ID: 38916667
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparison of efficacy and side-effect profile of oral PUVA vs. oral PUVA sol in the treatment of vitiligo: a 36-week prospective study.
    Singh S; Khandpur S; Sharma VK; Ramam M
    J Eur Acad Dermatol Venereol; 2013 Nov; 27(11):1344-51. PubMed ID: 23066663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
    Westerhof W; Nieuweboer-Krobotova L
    Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of vitiligo with oral methoxsalen and UVA.
    Lassus A; Halme K; Eskelinen A; Ranki A; Puska P; Salo O
    Photodermatol; 1984 Aug; 1(4):170-3. PubMed ID: 6531291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases.
    Silverberg NB; Lin P; Travis L; Farley-Li J; Mancini AJ; Wagner AM; Chamlin SL; Paller AS
    J Am Acad Dermatol; 2004 Nov; 51(5):760-6. PubMed ID: 15523355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The therapeutic effects of a topical tretinoin and corticosteroid combination for vitiligo: a placebo-controlled, paired-comparison, left-right study.
    Kwon HB; Choi Y; Kim HJ; Lee AY
    J Drugs Dermatol; 2013 Apr; 12(4):e63-7. PubMed ID: 23652908
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of vitiligo with topical trimethylpsoralen and sunlight.
    Africk J; Fulton J
    Br J Dermatol; 1971 Feb; 84(2):151-6. PubMed ID: 5548464
    [No Abstract]   [Full Text] [Related]  

  • 53. Long-term results of 2-mm punch grafting in patients with vitiligo vulgaris and segmental vitiligo: effect of disease activity.
    Fongers A; Wolkerstorfer A; Nieuweboer-Krobotova L; Krawczyk P; Tóth GG; van der Veen JP
    Br J Dermatol; 2009 Nov; 161(5):1105-11. PubMed ID: 19673878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone.
    Bansal S; Sahoo B; Garg V
    Photodermatol Photoimmunol Photomed; 2013 Dec; 29(6):311-7. PubMed ID: 24118425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A single-arm open-label clinical trial of autologous epidermal cell transplantation for stable vitiligo: A 30-month follow-up.
    Orouji Z; Bajouri A; Ghasemi M; Mohammadi P; Fallah N; Shahbazi A; Rezvani M; Vaezirad F; Khalajasadi Z; Alizadeh A; Taghiabadi E; Dashtbozorgi S; Aghdami R; Hosseini SE; Bahahrvand H; Shafieyan S; Aghdami N
    J Dermatol Sci; 2018 Jan; 89(1):52-59. PubMed ID: 29103774
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of latanoprost on vitiligo: a preliminary comparative study.
    Anbar TS; El-Ammawi TS; Abdel-Rahman AT; Hanna MR
    Int J Dermatol; 2015; 54(5):587-93. PubMed ID: 25545321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Experience with Meladinin treatment of patients with vitiligo].
    Shalupenko VN
    Vrach Delo; 1966 Aug; 8():139-40. PubMed ID: 5989145
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical repigmentation patterns in paediatric vitiligo.
    Gan EY; Gahat T; Cario-André M; Seneschal J; Ezzedine K; Taïeb A
    Br J Dermatol; 2016 Sep; 175(3):555-60. PubMed ID: 27037527
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas.
    Silpa-Archa N; Griffith JL; Huggins RH; Henderson MD; Kerr HA; Jacobsen G; Mulekar SV; Lim HW; Hamzavi IH
    J Am Acad Dermatol; 2017 Aug; 77(2):318-327. PubMed ID: 28502377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients.
    Schallreuter KU; Wood JM; Lemke KR; Levenig C
    Dermatology; 1995; 190(3):223-9. PubMed ID: 7599386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.